December 4, 2013
Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference
PORTLAND, Ore., Dec. 4, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will present a corporate update at the Oppenheimer 24th Annual Healthcare Conference. The presentation will take place on Tuesday, December 10, 2013 at 10:55 a.m. ET at the Crowne Plaza Hotel in New York, NY.
The presentation will be webcast and available on the Investors section of the Company's website at www.galenabiopharma.com.
About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit: www.galenabiopharma.com.
CONTACT: Remy Bernarda
Vice President, Marketing & Communications
(503) 405-8258
rbernarda@galenabiopharma.com
Close window | Back to top
